Post by Novotech

Name: It’s Day 3 of BIO 2026, and another trend is emerging in conversations with sponsors: the push to ge
Uploaded: 2026-06-25T03:21:40.001Z
Channel: Novotech
Description: It’s Day 3 of BIO 2026, and another trend is emerging in conversations with sponsors: the push to generate meaningful efficacy data earlier through more innovative clinical development strategies. Dr

136,592 followers

It’s Day 3 of BIO 2026, and another trend is emerging in conversations with sponsors: the push to generate meaningful efficacy data earlier through more innovative clinical development strategies. Dr. Judith Ng-Cashin, M.D., Chief Medical Officer at Novotech, shares how biotech companies are rethinking traditional development pathways with creative study designs to reach key value inflection points sooner. Hear her perspective on this evolving trend. #BIO2026 #Biotech #DrugDevelopment #ClinicalTrials

Video Content